Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00720486 · ClinicalTrials.gov registry record · NA

Effectiveness of Anger Management Treatment in Reducing Anger-Related Behaviors in Female Juvenile Offenders

A NA study of Anger, sponsored by naomi goldstein.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT00720486: Completed NA study of Anger, sponsored by naomi goldstein.

NCT00720486 is a NA study of Anger that has completed, run by naomi goldstein. The registered enrollment target is 75 participants, roughly in line with the 75-participant average among 10 other Anger trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00720486, a NA study of Anger, has completed, sponsored by naomi goldstein.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effectiveness of an anger management treatment program, Juvenile Justice Anger Management for Girls, in reducing anger-related behaviors displayed by girls in the juvenile justice system.

Conditions Studied

Interventions

  • BEHAVIORAL Treatment as usual
  • BEHAVIORAL Juvenile Justice Anger Management (JJAM) for Girls

Study Locations (1)

Pennsylvania

  • Drexel University - Philadelphia

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2008-06
Est. Completion 2012-02
Phase NA
naomi goldstein

1 total trials

What the finished NCT00720486 record still lists

NCT00720486 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, roughly in line with the 75-participant average among 10 other Anger trials with a reported enrollment target.

The record links to 1 condition, with Anger appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.

NCT00720486 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00720486 about?

NCT00720486 is a clinical study titled "Effectiveness of Anger Management Treatment in Reducing Anger-Related Behaviors in Female Juvenile Offenders". This study will evaluate the effectiveness of an anger management treatment program, Juvenile Justice Anger Management for Girls, in reducing anger-related behaviors displayed by girls in the juvenile justice system.

What is the current status of trial NCT00720486?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2008-06. Estimated completion is 2012-02.

What conditions does trial NCT00720486 study?

This clinical trial studies the following conditions: Anger.

What interventions are being tested in trial NCT00720486?

The interventions under investigation include: Treatment as usual (BEHAVIORAL), Juvenile Justice Anger Management (JJAM) for Girls (BEHAVIORAL).

Who is sponsoring clinical trial NCT00720486?

This trial is sponsored by naomi goldstein, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00720486 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anger

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00720486's enrollment target sits among peer trials

75 5th of 10 higher than 6 of 10 other Anger trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anger trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00720486, the US trial registry maintained by the National Library of Medicine. NCT00720486 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.